MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    GBA p.K198E mutation causing Parkinson Disease in Colombian population: the first clinical description

    L. Quintero-Giraldo, C. Moreno-López, C. Cerquera-Cleves (Bogota, Colombia)

    Objective: Describe the main clinical features of three subjects with inherited Parkinson's disease (PD) due to glucocerebrosidase (GBA) p.K198E substitution. Background: Recessive mutation of the…
  • 2023 International Congress

    Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital

    P. Paramanandam, A. S, A. Deenadayalu, I. N, K. Gowrishankar, T. Koshy (Chennai, India)

    Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…
  • 2023 International Congress

    Efficacy of melatonin in patients with insomnia and Parkinson’s disease

    A. Domínguez-García, DR. Aguila-Godinez, AA. Herrera-Ruiz, EC. Santiago-Delacruz, LG. Lira-Juárez, MAG. Medrano-Delgado, MA. Ruiz-Mafud, AJ. Hernández-Medrano, AY. Regalado-Mustafá, DP. Romero-Terán, MF. Medina-Pérez, GI. Cerda-Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez-Armesto, A. Abundes-Corona, A. Alcocer-Salas, K. Talavera-Lagunas (CDMX, Mexico)

    Objective: Determine the efficacy of melatonin in patients with Parkinson's disease suffering from insomnia. Background: Parkinson disease (PD) is a degenerative disease manifested by motor…
  • 2023 International Congress

    Functional Neuroimaging and Follow up trends in Drug induced movement disorders.

    V. Mathur, A. Shetty, H. Shah, V. Lele, P. Wadia (Jaipur, India)

    Objective: To analyse the role of presynaptic dopaminergic imaging (TRODAT/ F Dopa PET) scans to predict long-term outcomes in patients of new onset parkinsonian symptoms…
  • 2023 International Congress

    Case series of Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT); different presentations and different treatment outcomes.

    K. Methawasin, M. Jaisa-Aad (Nakhon Nayok, Thailand)

    Objective: to describe the characters of 4 female patients suffering from SREAT, phenotypes of movement disorders, cognitive impairment, and outcomes. Background: Steroid-responsive encephalopathy associated with…
  • 2023 International Congress

    Incidence of dysphagia and comorbidities in patients with cervical dystonia, analyzed by botulinum neurotoxin treatment exposure

    M. Sadeghi, A. Ukah, E. Yue, K. Becker Ifantides, N. Huang, J. Lee, R. Barbano (Irvine, USA)

    Objective: Describe real-world incidence of dysphagia and other comorbidities in adults with cervical dystonia (CD) treated and not treated with botulinum neurotoxin (BoNT). Background: Dysphagia…
  • 2023 International Congress

    Argentine Translation and Adaptation of the Scale for the Assessment and Classification of Ataxia (SARA)

    J. Fernández Boccazzi, N. Gonzalez Rojas, M. Cesarini, G. da Prat, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: Translate and cross-culturally adapt this instrument into Spanish and to carry out a pilot test for its subsequent validation in this language. Background: Ataxias…
  • 2023 International Congress

    Cervical dystonia with early onset as initial manifestation of adult-onset Huntington’s disease

    I. šarac, H. šarac, F. Borovečki, N. Božina, J. Sertić, I. Ivek, L. Bagarić Krakan, Z. Krešić (Zagreb, Croatia)

    Objective: To describe a rare case of adult-onset HD that presented with early-onset cervical dystonia as the only and prominent symptom. Background: Except for chorea,…
  • 2023 International Congress

    Developement and acceptability testing of a patient decision aid on levodopa/carbidopa intestinal gel.

    C-C. Cayer, IBB. Beaulieu-Boire, A-T. Tanguay (Sherbrooke, Canada)

    Objective: To develop a patient decision aid on levodopa/carbidopa intestinal gel (LCIG) and to test its acceptability. Background: : Advanced Parkinson’s disease (PD) is characterized…
  • 2023 International Congress

    ELectronic Archimedes spiral Neural Network (ELANN)

    J. Holcomb, J. Maldjian, Y. Xi, P. O’Suilleabhain, E. Louis, B. Shah (Dallas, USA)

    Objective: This study sought to generate a standard model for essential tremor (ET) evaluation using a convolutional neural network (CNN). Background: The Archimedes spiral is…
  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley